MAP3K1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.571200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.704000E-01
Normal-vs-Stage2
2.666800E-01
Normal-vs-Stage3
2.053400E-01
Normal-vs-Stage4
1.379770E-01
Stage1-vs-Stage2
9.857600E-01
Stage1-vs-Stage3
1.843760E-01
Stage1-vs-Stage4
8.780000E-01
Stage2-vs-Stage3
1.536390E-01
Stage2-vs-Stage4
8.316400E-01
Stage3-vs-Stage4
3.620800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.552000E-01
Normal-vs-AfricanAmerican
3.300800E-01
Normal-vs-Asian
2.510400E-01
Caucasian-vs-AfricanAmerican
1.462420E-01
Caucasian-vs-Asian
7.846400E-01
AfricanAmerican-vs-Asian
2.454600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.566200E-01
Normal-vs-Female
2.586400E-01
Male-vs-Female
8.931000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.396000E-01
Normal-vs-Age(41-60Yrs)
2.882600E-01
Normal-vs-Age(61-80Yrs)
2.446200E-01
Normal-vs-Age(81-100Yrs)
2.372600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.889800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.840000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.759600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.116310E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.648100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.531600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.722800E-01
Normal-vs-Daily Drinker
2.401800E-01
Normal-vs-Weekly Drinker
2.139800E-01
Normal-vs-Occasional Drinker
2.566200E-01
Normal-vs-Social Drinker
2.587600E-01
Non Drinker-vs-Daily Drinker
2.537000E-01
Non Drinker-vs-Weekly Drinker
6.214300E-02
Non Drinker-vs-Occasional Drinker
6.194400E-01
Non Drinker-vs-Social Drinker
6.829400E-01
Daily Drinker-vs-Weekly Drinker
2.703600E-01
Daily Drinker-vs-Occasional Drinker
5.375000E-01
Daily Drinker-vs-Social Drinker
5.032000E-01
Weekly Drinker-vs-Occasional Drinker
1.306400E-01
Weekly Drinker-vs-Social Drinker
1.237030E-01
Occasional Drinker-vs-Social Drinker
9.483000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.349370E-01
Normal-vs-Grade 2
1.429640E-02
Normal-vs-Grade 3
4.378500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.973400E-01
Grade 1-vs-Grade 3
2.817800E-01
Grade 1-vs-Grade 4
1.349370E-01
Grade 2-vs-Grade 3
4.697800E-01
Grade 2-vs-Grade 4
1.429640E-02
Grade 3-vs-Grade 4
4.378500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.544800E-01
Normal-vs-NonDiabetic
2.461200E-01
Diabetic-vs-NonDiabetic
6.246800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.411400E-01
Normal-vs-NoPancreatitis
2.518000E-01
Pancreatitis-vs-NoPancreatitis
6.393400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.380600E-01
Normal-vs-N1
2.680200E-01
N0-vs-N1
5.682100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.828800E-01
Normal-vs-TP53-NonMutant
2.874000E-01
TP53-Mutant-vs-TP53-NonMutant
8.612000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
